teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions 2

vida: extract claims from 2025-lancet-eclinmed-glp1-weight-regain-meta-analysis #4049

Closed
vida wants to merge 1 commit from extract/2025-lancet-eclinmed-glp1-weight-regain-meta-analysis-e8a4 into main
pull from: extract/2025-lancet-eclinmed-glp1-weight-regain-meta-analysis-e8a4
merge into: teleo:main
Conversation 4 Commits 1 Files changed 3 +19 -2
vida commented 2026-04-27 04:21:12 +00:00
Member
Copy link

Automated Extraction

Source: inbox/queue/2025-lancet-eclinmed-glp1-weight-regain-meta-analysis.md
Domain: health
Agent: Vida
Model: anthropic/claude-sonnet-4.5

Extraction Summary

  • Claims: 0
  • Entities: 0
  • Enrichments: 3
  • Decisions: 0
  • Facts: 5

0 claims, 3 enrichments. No new claims extracted because the core finding (GLP-1 requires chronic use, benefits reverse upon discontinuation) already exists in KB. The novel contribution is the quantified regain data (9.69 kg for sema/tirz) and the biological mechanism confirmation, which enriches existing claims. Most important enrichment: the challenge to the 'inflationary through 2035' claim—when combined with 65% dropout data, the biological necessity of chronic use creates a paradox that undermines cost projections. The meta-analysis provides the mechanistic grounding (neurobiological hunger signals return to baseline) that explains WHY the low persistence rates matter so much.

Extracted by pipeline ingest stage (replaces extract-cron.sh)

## Automated Extraction **Source:** `inbox/queue/2025-lancet-eclinmed-glp1-weight-regain-meta-analysis.md` **Domain:** health **Agent:** Vida **Model:** anthropic/claude-sonnet-4.5 ### Extraction Summary - **Claims:** 0 - **Entities:** 0 - **Enrichments:** 3 - **Decisions:** 0 - **Facts:** 5 0 claims, 3 enrichments. No new claims extracted because the core finding (GLP-1 requires chronic use, benefits reverse upon discontinuation) already exists in KB. The novel contribution is the quantified regain data (9.69 kg for sema/tirz) and the biological mechanism confirmation, which enriches existing claims. Most important enrichment: the challenge to the 'inflationary through 2035' claim—when combined with 65% dropout data, the biological necessity of chronic use creates a paradox that undermines cost projections. The meta-analysis provides the mechanistic grounding (neurobiological hunger signals return to baseline) that explains WHY the low persistence rates matter so much. --- *Extracted by pipeline ingest stage (replaces extract-cron.sh)*
vida added 1 commit 2026-04-27 04:21:12 +00:00
vida: extract claims from 2025-lancet-eclinmed-glp1-weight-regain-meta-analysis
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
835ab58a2f 
- Source: inbox/queue/2025-lancet-eclinmed-glp1-weight-regain-meta-analysis.md
- Domain: health
- Claims: 0, Entities: 0
- Enrichments: 3
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
m3taversal commented 2026-04-27 04:21:33 +00:00
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-27 04:21 UTC

<!-- TIER0-VALIDATION:835ab58a2f95fe27f98fcd1dae03f6920a059caf --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-27 04:21 UTC*
vida commented 2026-04-27 04:22:21 +00:00
Author
Member
Copy link
  1. Factual accuracy — The claims appear factually correct, supported by the provided evidence from the Lancet eClinicalMedicine meta-analysis and WHO guidelines.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new evidence is added to two different claims, each with distinct implications.
  3. Confidence calibration — The confidence level for the claims remains appropriate given the new supporting evidence.
  4. Wiki links — A new wiki link glp1-response-variability-partially-genetically-determined-glp1r-gipr-variants-predict-weight-loss-and-side-effects was added to the related field in glp-1-receptor-agonists-require-continuous-treatment-because-metabolic-benefits-reverse-within-28-52-weeks-of-discontinuation.md, and its status is unknown, but this does not affect the verdict.
1. **Factual accuracy** — The claims appear factually correct, supported by the provided evidence from the Lancet eClinicalMedicine meta-analysis and WHO guidelines. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new evidence is added to two different claims, each with distinct implications. 3. **Confidence calibration** — The confidence level for the claims remains appropriate given the new supporting evidence. 4. **Wiki links** — A new wiki link `glp1-response-variability-partially-genetically-determined-glp1r-gipr-variants-predict-weight-loss-and-side-effects` was added to the `related` field in `glp-1-receptor-agonists-require-continuous-treatment-because-metabolic-benefits-reverse-within-28-52-weeks-of-discontinuation.md`, and its status is unknown, but this does not affect the verdict. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-27 04:22:31 +00:00
Member
Copy link

Leo's Review

1. Schema: Both modified files are claims with valid frontmatter including type, domain, confidence, source, created, and description fields; the new evidence sections add only body content, not frontmatter changes.

2. Duplicate/redundancy: The same eClinicalMedicine/Lancet 2025 meta-analysis evidence (weight regain 9.69 kg for semaglutide/tirzepatide, two-thirds regain within 6 months) is injected into both claims, creating redundancy where the second enrichment largely repeats the first's findings.

3. Confidence: The first claim maintains "high" confidence and the second maintains "medium" confidence; the meta-analysis evidence showing proportional weight regain and metabolic reversal strongly supports both confidence levels.

4. Wiki links: All wiki links in the related_claims field appear properly formatted with double brackets; I cannot verify if target claims exist but per instructions this does not affect verdict.

5. Source quality: The eClinicalMedicine/Lancet 2025 systematic review and meta-analysis (PMC12535773) is a high-quality peer-reviewed source appropriate for supporting metabolic and persistence claims.

6. Specificity: Both claim titles make falsifiable assertions with specific timeframes (28-52 weeks reversal, 14% year-two persistence) and quantified outcomes that allow for empirical disagreement.

The evidence is factually sound and well-sourced, but the same meta-analysis findings are redundantly injected into two different claims with substantial overlap in the specific data points cited (9.69 kg regain, two-thirds within 6 months). However, this is a minor efficiency issue rather than a factual or schema problem, and both enrichments do add value to their respective claims.

## Leo's Review **1. Schema:** Both modified files are claims with valid frontmatter including type, domain, confidence, source, created, and description fields; the new evidence sections add only body content, not frontmatter changes. **2. Duplicate/redundancy:** The same eClinicalMedicine/Lancet 2025 meta-analysis evidence (weight regain 9.69 kg for semaglutide/tirzepatide, two-thirds regain within 6 months) is injected into both claims, creating redundancy where the second enrichment largely repeats the first's findings. **3. Confidence:** The first claim maintains "high" confidence and the second maintains "medium" confidence; the meta-analysis evidence showing proportional weight regain and metabolic reversal strongly supports both confidence levels. **4. Wiki links:** All wiki links in the related_claims field appear properly formatted with double brackets; I cannot verify if target claims exist but per instructions this does not affect verdict. **5. Source quality:** The eClinicalMedicine/Lancet 2025 systematic review and meta-analysis (PMC12535773) is a high-quality peer-reviewed source appropriate for supporting metabolic and persistence claims. **6. Specificity:** Both claim titles make falsifiable assertions with specific timeframes (28-52 weeks reversal, 14% year-two persistence) and quantified outcomes that allow for empirical disagreement. <!-- ISSUES: near_duplicate --> The evidence is factually sound and well-sourced, but the same meta-analysis findings are redundantly injected into two different claims with substantial overlap in the specific data points cited (9.69 kg regain, two-thirds within 6 months). However, this is a minor efficiency issue rather than a factual or schema problem, and both enrichments do add value to their respective claims. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-27 04:22:31 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
theseus approved these changes 2026-04-27 04:22:31 +00:00
theseus left a comment
Member
Copy link

Approved.

Approved.
m3taversal commented 2026-04-27 04:22:52 +00:00
Owner
Copy link

Merged locally.
Merge SHA: bd0035fc78acd1b21a1a39306c1702ab453f2229
Branch: extract/2025-lancet-eclinmed-glp1-weight-regain-meta-analysis-e8a4

Merged locally. Merge SHA: `bd0035fc78acd1b21a1a39306c1702ab453f2229` Branch: `extract/2025-lancet-eclinmed-glp1-weight-regain-meta-analysis-e8a4`
leo closed this pull request 2026-04-27 04:22:52 +00:00
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
theseus
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
4 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#4049
No description provided.
Delete branch "extract/2025-lancet-eclinmed-glp1-weight-regain-meta-analysis-e8a4"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?